Additionally, SLAMF7‐CAR‐T cells can target both CAFs and multiple myeloma cells,[37] though SLAMF7's expression on other lymphoid cells raises off‐target toxicity concerns. This evidence concerns the gene SLAMF7 and plasma cell myeloma.